Christiane Sybille Schmidt, Dipl. Psychologin

Wissenschaftliche Mitarbeiterin

Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg

c/o UKE, Klinik und Poliklinik für Psychiatrie und Psychotherapie
Martinistr. 52

20246 Hamburg

Tel.: 040 7410 57906

Fax: 040 7410 58351

eMail: christiane.schmidt@uke.de

Lebenslauf

Interessensschwerpunkt

• Alkoholbezogene Kurzinterventionen
• Evaluation psychotherapeutischer Interventionen
• Wissenschaftliche Methodik
• Klinische Neuropsychologie

Projekte

• Suchtrehabilitation von Opioidabhängigen in Behandlung mit injizierbarem, subkutanem Depot-Buprenorphin (ARIDE)
• Scale-up of Prevention and Management of Alcohol Use Disorders and Comorbid Depression in Latin America
• Implementierung und Evaluation der S3-Leitlinie zu Screening, Diagnose und Behandlung alkoholbezogener Störungen
• INFO - Studie: HCV Therapie bei Opioidsubstituierten
• Epidemiologie der Hepatitis-C-Virus Infektion bei Opioidsubstituierten

Publikationen

Originalarbeiten

• Anderson P, Manthey J, Llopis EJ, Rey GN, Bustamante IV, Piazza M, Aguilar PSM, Mejía-Trujillo J, Pérez-Gómez A, Rowlands G, Lopez-Pelayo H, Mercken L, Kokole D, O'Donnell A, Solovei A, Kaner E, Schulte B, de Vries H, Schmidt C, Gual A, Rehm J. (2021) Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial. J Gen Intern. doi: 10.1007/s11606-020-06503-9
• Kalke J, Schmidt CS, Hayer T. Sportwetten: Expertise oder Glück? Ein systematischer Review über Tippstudien. Suchttherapie 2020. eFirst - DOI https://doi.org/10.1055/a-1226-7351
• Schulte B, Schmidt CS, Manthey J, Strada L, Christensen S, Cimander K, Görne H, Khaykin P, Scherbaum N, Walcher S, Mauss S, Schäfer I, Verthein U, Rehm J,  Reimer J (2020) Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study. Open Forum Infectious Diseases, https://doi.org/10.1093/ofid/ofaa317
• Jané-Llopis E, Anderson P, Piazza M, O'Donnell A, Gual A, Schulte B, Pérez Gómez A, de Vries H,  Natera Rey G, Kokole D, Bustamante I, Braddick F, Mejía Trujillo J, Solovei A, Pérez De León A, Kaner E, Matrai S, Manthey J, Mercken L, López-Pelayo H, Rowlands G, Schmidt C, Rehm J (2020) Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study). BMJ Open, http://dx.doi.org/10.1136/bmjopen-2020-038226
• Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer
  J (2020) Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis 6;70:2199-2205. doi: 10.1093/cid/ciz661
• Reiß M, Schulte B, Schmidt CS, Carstens A, Görne H, Kreibich R, Tietje W, Weber B, Schnell T, Verthein U (2020) Selbst- und Fremdbeurteilung von Depressivität bei opioidabhängigen Patienten in Substitutionsbehandlung. Suchttherapie, 21: 25-31. DOI: 10.1055/a-1032-6735
• Schulte B, Kaner EFS, Beyer F, Schmidt CS, O'Donnell A (2019) Study protocol for a
  systematic review of evidence for digital interventions for comorbid excessive
  drinking and depression in community-dwelling populations. BMJ Open; 17;9:e031503. doi: 10.1136/bmjopen-2019-031503
• Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B (2019) Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy; 14:2
• Schmidt CS, Schulte B, Seo HN, Kuhn S, O Donnell A, Kriston L, Verthein U, Reimer J. (2016). Meta-analysis on the effectiveness of alcohol screening with brief interventions for patients in emergency care settings. Addiction. 2015 Dec 5. doi: 10.1111/add.13263
• Schulte B, Schmidt CS, Strada L, Götzke C, Hiller P, Fischer B, Reimer J (2016). Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users. Int J Drug Pol doi:10.1016/j.drugpo.2015.12.024
• Strada L, Schulte B, Schmidt CS, Verthein U, Cremer-Schaeffer P, Kru?ckeberg S, Reimer J (2015) Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): Study protocol. BMC Infectious Diseases (2015) 15:563 DOI 10.1186/s12879-015-1307-z
• O’Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Kaner E. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcoholism 2014; 49: 66-78.
• Schmidt CS, McGovern R, Schulte B, O'Donnell A, Lehmann K, Kuhn S, Schäfer I, Newbury-Birch D, Anderson P, Kaner E, Reimer J. Brief Alcohol Interventions in Social Service and Criminal Justice Settings: A Critical Commentary. Br J Soc Work 2014 doi: 10.1093/bjsw/bcu100
• Schulte B, O`Donnell A, Kastner S, Schmidt CS, Schäfer I, Reimer J. Alcohol screening and brief intervention in workplace settings and social services: A comparison of literature. Front. Psychiatry 2014 doi: 10.3389/fpsyt.2014.00131
• Schmidt CS, Schön D, Schulte B, Lüth S, Polywka S, Reimer J. Viral hepatitis in alcohol-dependent inpatients – Prevalence, risk factors and treatment uptake. Journal of Addiction Medicine 2013; 7:417-21. doi: 10.1097/ADM.0b013e3182a50817
• Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein U, Backmund M. Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.Clin Infect Dis. 2013 Aug;57 Suppl 2:S97-104. doi: 10.1093/cid/cit307.
• Schulte B, Schmidt CS, Schäfer I, Fischer B, Wedemeyer H, ReimerJ. Structural barriers in the context of opiate substitution treatment in Germany. Substance Abuse, Treatment, Prevention & Policy 2013; 8:26
• Schulte B, Schmidt CS, Milin S, Farnbacher G, Schäfer I, Hillemacher T, Kiefer F, Bleich S, Reimer J (2013) Barrieren und Möglichkeiten in der Umsetzung von alkoholbezogenen Interventionen in der hausärztlichen Praxis. Suchttherapie 2014; 15: 35-42.
• O’Donnell A, Kaner E, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, Anderson P. Efficacious, effective but still erratic: what will it take to get routine delivery of brief interventions for alcohol in primary healthcare settings? Alcohol & Alcoholism 2013; 49 doi:10.1093/alcalc/agt170
• Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J. Non-prescribed use of substitution medication among German drug users – Prevalence, motives and availability. International Journal of Drug Policy,  2013;24:e111-4. doi:10.1016/j.drugpo.2013.04.006